Mei-Chuan Ko to Ligands
This is a "connection" page, showing publications Mei-Chuan Ko has written about Ligands.
Connection Strength
0.906
-
Kiguchi N, Ko MC. Potential therapeutic targets for the treatment of opioid abuse and pain. Adv Pharmacol. 2022; 93:335-371.
Score: 0.205
-
Kiguchi N, Ko MC. Effects of NOP-Related Ligands in Nonhuman Primates. Handb Exp Pharmacol. 2019; 254:323-343.
Score: 0.169
-
Ding H, Kiguchi N, Yasuda D, Daga PR, Polgar WE, Lu JJ, Czoty PW, Kishioka S, Zaveri NT, Ko MC. A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med. 2018 08 29; 10(456).
Score: 0.165
-
Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Proc Natl Acad Sci U S A. 2016 09 13; 113(37):E5511-8.
Score: 0.143
-
Sukhtankar DD, Zaveri NT, Husbands SM, Ko MC. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/ยต-opioid receptor ligands in mouse models of neuropathic and inflammatory pain. J Pharmacol Exp Ther. 2013 Jul; 346(1):11-22.
Score: 0.114
-
Ko MC, Divin MF, Lee H, Woods JH, Traynor JR. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey. J Pharmacol Exp Ther. 2006 Feb; 316(2):772-9.
Score: 0.068
-
Ko MC, Butelman ER, Woods JH. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther. 1999 Apr; 289(1):378-85.
Score: 0.043